Pharmstandard International: Funding, Team & Investors | Startup Intros

Loading organizations...

Pharmstandard International: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 5, 2017	Neon Therapeutics	$36.0M Series B Extension	—	Access Industries, ArrowMark Partners, Casdin Capital, Fidelity Management & Research Company, Hillhouse Capital Group, Nextech Invest, Partner Fund Management, Wellington Management
Aug 1, 2016	Avelas Biosciences	$20.0M Series C	Andrei Petrov	Avalon Ventures, Alexandria Venture Investments, Bregua Corporation, Ervington Investments, WuXi Healthcare Ventures
Dec 1, 2015	Allena Pharmaceuticals	$53.0M Series C	Partner Fund Management	Frazier Healthcare Partners, Markus Goebel, Fidelity Management & Research Company, HBM Partners, Wellington Management
Jul 1, 2015	Protagonist Therapeutics	$40.0M Series C	Canaan Partners	Adage Capital Management, Foresite Capital, Johnson & Johnson Innovation, Lilly Ventures, RA Capital Management, Starfish Ventures
Apr 23, 2015	Jounce Therapeutics, Inc.	$56.0M Series B	—	Casdin Capital, Cormorant Asset Management, Foresite Capital, Nextech Invest, Omega Funds, Michael Lee, Wellington Management
Dec 1, 2014	Allena Pharmaceuticals	$25.0M Series B	HBM Partners	Atlas Venture, Bessemer Venture Partners, Frazier Healthcare Partners, Third Rock Ventures, Ysios Capital, Markus Goebel
May 16, 2014	Proteon Therapeutics	$45.0M Series D	Tim Haines	Bessemer Venture Partners, Deerfield Management, Devon Park Bioventures, Intersouth Partners, MPM Capital, Dmitry Kobyzev, Ph.D., Prism VentureWorks, Skyline Ventures, TVM Capital, Vectis Healthcare and Life Sciences Fund
Nov 20, 2013	Argos Therapeutics	$17.5M Series E Extension	—	Aurora Funds, Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, TVM Capital
Sep 19, 2013	Protagonist Therapeutics	$4.0M Series B Extension	Pharmstandard International	—
Aug 28, 2013	Argos Therapeutics	$42.5M Series E	Alexandr Shuster	Aurora Funds, Forbion, Green Cross Holdings, Intersouth Partners, Lumira Ventures, Morningside, TVM Capital